Correction: Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study (PLoS ONE (2017) 12:4 (e0173299) DOI: 10.1371/journal.pone.0173299)

Garrick D. Talmage, Oscar J.M. Coppes, Adil Javed, Jacqueline Bernard

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Correction: Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study (PLoS ONE (2017) 12:4 (e0173299) DOI: 10.1371/journal.pone.0173299)'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds

Agriculture & Biology